SEC Form 4/A · accession 0001209191-16-115058
Intra-Cellular Therapies, Inc. · ITCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Rory B Riggs
Director
Period of report
Feb 5, 2014
Accepted (ET)
Apr 20, 2016 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 5, 2014 | P | 14,286 | $17.50 | A | 226,670 | I | Held by New Ventures I, LLC |
| Common StockF1 | Feb 5, 2014 | P | 14,285 | $17.50 | A | 26,091 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects shares purchased in the Issuer's public offering, which closed on February 5, 2014.
- F2Mr. Riggs is Managing Member of New Ventures I, LLC and may be deemed to beneficially own the securities held by New Ventures I, LLC. Mr. Riggs disclaims beneficial ownership of the securities held by New Ventures I, LLC except to the extent of his pecuniary interest therein.
Remarks
The original Form 4 reported that an aggregate of 28,571 shares were purchased by New Ventures I, LLC in the Issuer's public offering, which closed on February 5, 2014; however, 14,286 shares were purchased by New Ventures I, LLC and 14,285 shares were purchased by Mr. Riggs in the offering.